Skip to main content
News > News > Open Therapeutics Trending with Academia and Professionals

Open Therapeutics Trending with Academia and Professionals

June 4, 2015. University of Oxford, Structural Genomics Consortium published a paper in PLOS Biology titled

Open Access Target Validation Is a More Efficient Way to Access Drug Discovery (CC By Wen Hwa Lee).


June 16, 2015. Deloitte released a series of Open Innovation papers including:

Executing an open innovation model – Cooperation is key to competition for biopharmaceutical companies.

Health Care Current: June 16, 2015. Building an open innovation approach to R&D.


To comment, please visit: Open Therapeutics (CC BY Jin Kong – June 18, 2015)

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.